Mizuho Raised Waystar Target to $50, Reaffirmed Outperform After Q3 Strength

Waystar Holding Corp. (NASDAQ:WAY) is a leading player in the digital health sector, making it one of the best digital health stocks to consider investing in. Mizuho Securities recently raised their target price for WAY from $48 to $50 after the company reported strong third-quarter earnings. The firm maintained an Outperform rating on the stock, attributing the positive performance to the high demand for Waystar’s revenue cycle management solutions. Specifically, the adoption of AI-driven claims denial tools was highlighted as a key factor driving the company’s above-consensus results.

Following the release of its Q3 report on October 29, 2025, Waystar Holding Corp. demonstrated double-digit growth driven by steady transaction volume, increasing client adoption, and early cross-selling opportunities with Iodine Software. These factors contributed to a 12% revenue growth, reaching $268.7 million, while adjusted EBITDA remained strong at $112.7 million with a 42% margin. The company’s cost discipline and scale efficiencies further enhanced profitability, resulting in a net income of $30.6 million. Management raised full-year targets, indicating confidence in the continued momentum fueled by the Iodine integration and pipeline. Revenue targets for the year were adjusted to $1.085–$1.093 billion, with adjusted EBITDA expected to range between $451–$455 million.

Waystar Holding Corp. specializes in healthcare payments and revenue cycle technology, offering cloud-based software solutions for hospitals, physician groups, and other healthcare organizations. Their software aids in managing claims processing, billing, prior authorizations, and patient financial interactions.

While Waystar Holding Corp. (NASDAQ:WAY) presents a promising investment opportunity, there are other AI stocks in the market that may offer greater upside potential with less downside risk. For those seeking an undervalued AI stock that could benefit from current market trends, exploring alternative investment options may be worthwhile.

In conclusion, Waystar Holding Corp. continues to demonstrate strength in the digital health sector, with a focus on innovative solutions for healthcare revenue cycle management. Investors looking to capitalize on the evolving landscape of healthcare technology should keep an eye on WAY as a potential investment opportunity.

Disclosure: None.